Efficacy and safety of adjunctive perampanel in patients with focal seizures or generalized tonic‐clonic seizures: Post hoc analysis of Phase II and Phase III double‐blind and open‐label extension studies in India
Abstract Objective This post hoc analysis assessed the efficacy and safety of adjunctive perampanel in patients (aged ≥ 12 years) with focal seizures (FS), with/without focal to bilateral tonic‐clonic seizures (FBTCS), or generalized tonic‐clonic seizures (GTCS) in India. Methods Centers in India we...
Main Authors: | Man M. Mehndiratta, Manoj Gulhane, Shaik A. Jabeen, Anna Patten, Amitabh Dash, Manoj Malhotra |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-03-01
|
Series: | Epilepsia Open |
Subjects: | |
Online Access: | https://doi.org/10.1002/epi4.12448 |
Similar Items
-
Long‐term open‐label perampanel: Generalized tonic–clonic seizures in idiopathic generalized epilepsy
by: Jacqueline A. French, et al.
Published: (2022-09-01) -
Intravenous perampanel as an alternative to the oral formulations in Japanese patients with epilepsy
by: Ryosuke Hanaya, et al.
Published: (2023-12-01) -
Efficacy and safety of perampanel monotherapy in Chinese patients with focal‐onset seizures: A single‐center, prospective, real‐world observational study
by: Haiyan Ma, et al.
Published: (2023-12-01) -
The adolescent or adult with generalized tonic-clonic seizures
by: Roop Gursahani, et al.
Published: (2012-01-01) -
Perampanel in the additional therapy of focal and primary generalized tonic-clonic seizures in children 4–12 years old: clinical data, experience of use and practical recommendations
by: K. Yu. Mukhin, et al.
Published: (2021-07-01)